CSE:RVV - Post Discussion
Post by
CrazyProphet on Apr 28, 2022 7:34am
Hourglass almost done !
Merck sold $3.2 billion of its oral antiviral treatment for Covid in the first quarter, fueling the company’s strong revenue growth.
Merck soundly beat Wall Street profit and revenue forecasts ?
Revive looking more & more like a buyout
when patience pays it pays
Be the first to comment on this post